BlackRock
FMTX

BlackRock’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

BlackRock’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,632,271
Closed -$72.5M – 5982
2022
Q3 		$72.5M Buy
3,632,271
+513,211
+16% +$6.77M ﹤0.01% 2165
2022
Q2 		$21.5M Buy
3,119,060
+100,775
+3% +$707K ﹤0.01% 3052
2022
Q1 		$28.1M Sell
3,018,285
-8,381
-0.3% -$89.2K ﹤0.01% 2956
2021
Q4 		$43M Sell
3,026,666
-383,020
-11% -$6.63M ﹤0.01% 2755
2021
Q3 		$79.1M Buy
3,409,686
+75,561
+2% +$1.79M ﹤0.01% 2361
2021
Q2 		$83M Buy
3,334,125
+44,549
+1% +$1.2M ﹤0.01% 2372
2021
Q1 		$92.2M Buy
3,289,576
+654,826
+25% +$23.6M ﹤0.01% 2236
2020
Q4 		$92M Buy
2,634,750
+1,176,982
+81% +$51.2M ﹤0.01% 2136
2020
Q3 		$72.7M Buy
1,457,768
+897,916
+160% +$36.3M ﹤0.01% 2076
2020
Q2 		$26M Buy
+559,852
New +$24.3M ﹤0.01% 2658

BlackRock's FMTX Position: Q4 2022 in Review

BlackRock sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 3,632,271 shares — an estimated $72.5M sold.

BlackRock first reported a position in FMTX in Q2 2020 and held it in 10 quarters. The position peaked at $92.2M in Q1 2021. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • BlackRock reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • BlackRock sold 3,632,271 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $72.5M.
  • BlackRock first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
  • BlackRock's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $92.2M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on BlackRock's 13F filing for Q4 2022, filed 13 Feb 2023.